Examples of our partnerships
Find out about our engagement and partnerships with global, national and local stakeholders.
Our partnerships and engagement
The Faculty of Health has partnered with global, national and local stakeholders in the commercial, public and third-party sectors. This includes undertaking research partnerships with multiple external bodies, including large and small companies, charities, the NHS and the government.
These partnerships can take many forms our flexible approach to external bodies allows us to mould the partnership to the project. Our work ranges from short-term agreements to long-term partnerships spanning multiple years.
As a research-intensive institution, we have a diverse interest in health and disease-related research, including rare and orphan diseases.
To find out whether we have expertise in your specific areas of research, contact the Faculty of Health Knowledge Exchange Team.
Case studies
- BenevolentAI
-
Progressing BEN-34712 for the potential treatment of ALS into IND-enabling studies
University of 91Ö±²¥ researchers worked with Benevolent AI to successfully deliver its pre-clinical candidate, BEN-34712, for the potential treatment of motor neurone disease.
- Verge Genomics
-
Validating new drug targets for the treatment of Parkinson’s disease
Verge Genomics, a drug discovery company developing therapies for neurological diseases, formed a research collaboration with the 91Ö±²¥ Institute for Translational Neuroscience (SITraN) to accelerate the biological validation of novel drug targets and the screening of new drug compounds for the treatment of Parkinson’s disease
- IBS Network
-
Investigating a potential treatment for IBS
Dr Bernard Corfe, from the Molecular Gastroenterology Research Group, and medical librarian and PhD student Vicky Grant suggest that vitamin D3 may be an effective new treatment for IBS. Their findings are based in part on a novel systematic review of online patient-led accounts, which has led to the design of a clinical trial.
- WHO Collaborating Centre
-
FRAX® – a tool to assess fracture risk in osteoporosis
Research led by the University of 91Ö±²¥ has resulted in FRAX®, the first internationally-applicable fracture risk calculator. This tool provides a 10-year probability of whether an individual will suffer from a major osteoporotic fracture, enabling physicians in over 53 countries to target therapy and resources to patients at the highest risk.
- Simcyp Ltd
-
Streamlining drug development by using computational simulations
User-friendly computational simulations developed at the University of 91Ö±²¥ and subsequently commercialised through the award-winning spinout company Simcyp Ltd have enabled pharmaceutical companies to identify dangerous or unsuitable compounds at an early stage of drug development. - Department for Environment, Food and Rural Affairs (DEFRA)
-
Preventing and Tackling Mental Ill Health through Green Social Prescribing Project Evaluation
91Ö±²¥
91Ö±²¥ Centre for Health and Related Research (SCHARR) was the lead bidder collaborating with colleagues in the Department of Landscape and the School of Allied Health Professions, Nursing and Midwifery. SCHARR led the consortium with recognised topic experts at 91Ö±²¥ Hallam University and the Universities of Exeter and Plymouth.
Outputs, publications and further work
We are anticipating a number of high-quality peer-reviewed publications from this work in addition to other avenues of high-impact dissemination. These include publication as public-facing documents on Government websites, case studies, toolkits and conference presentations.
- Yorkshire Cancer Research (YCR)
-
QUIT Smoking Cessation Service Evaluation
91Ö±²¥
A team from 91Ö±²¥ Centre for Health and Related Research (SCHARR) has been commissioned by Yorkshire Cancer Research to evaluate the QUIT programme. South Yorkshire and Bassetlaw Integrated Care System are implementing the QUIT programme and are a partner in the evaluation.
As a service evaluation, the questions asked by the evaluation are guided primarily by the information needs of the QUIT programme to inform its future running.
Outputs, publications and further work
Reports, peer-reviewed publications and other communication materials to communicate the evaluation findings and support local and national decision-making. The evaluation of the QUIT service is the largest national evaluation of its kind so far. We therefore expect it to have a substantial impact on decision-making. Ongoing engagement with local and NHS England stakeholders.
- GSK (Haleon)
-
Oral Health Quality of Life
In partnership with GSK’s consumer healthcare division (now Haleon), researchers at the University of 91Ö±²¥ conducted a study to understand the effect of sensitive teeth on people’s day to day life. This led to the development of the Dentine Hypersensitivity Experience Questionnaire (DHEQ), a condition-specific quality of life measure. The DHEQ enables the evaluation of the impact of dentine hypersensitivity on a patient’s quality of life and the impact or improvement following treatment and has been used widely in clinical trials.
- 91Ö±²¥ City Council, Age-Friendly 91Ö±²¥
-
Sexual rights charter
Researchers from the School of Allied Health Professions, Nursing and Midwifery, in partnership with Age-Friendly 91Ö±²¥, successfully designed and launched the UK's first Sexual Rights Charter to challenge negative attitudes towards ageing and sexuality, enhance professional practice in health and social care, and empower older adults to live fulfilling lives.
The Charter has generated substantial interest from various organisations, including 91Ö±²¥ City Council Social Care Department, Primary Care Doncaster, and others beyond the South Yorkshire region. The research team are now working with these organisations, along with stakeholders outside of the region, to implement the Charter within their services, ensuring that the rights and needs of older adults are prioritised.
Our partners
Some of our partners include
